Key result
An admission neutrophil count ≥7,260 cells/mm³ was an independent predictor of long-term adverse cardiac events in patients treated with primary angioplasty for acute myocardial infarction.
Why the study?
Does a high admission neutrophil count predict long-term adverse cardiac events in patients treated with primary angioplasty for anterior wall acute myocardial infarction?
Cohort (n=228)
No
Does a high admission neutrophil count predict long-term adverse cardiac events in patients treated with primary angioplasty for anterior wall acute myocardial infarction?
An elevated admission neutrophil count (≥7,260 cells/mm³) is a simple, noninvasive marker that independently predicts impaired microvascular perfusion, left ventricular dilation, and long-term adverse cardiac events in patients undergoing primary angioplasty for anterior AMI.
Answers are grounded in this paper and cite their sources.
May aid risk stratification post-primary PCI; leaves open whether neutrophil-targeted therapies alter long-term outcomes.
BACKGROUND: The relationship of admission neutrophil count to the degree of microvascular injury, left ventricular (LV) volume, and long-term outcome after acute myocardial infarction (AMI) was examined in the present study. METHODS AND RESULTS: The study group comprised 228 consecutive patients with a first anterior wall AMI who underwent primary angioplasty within 12 h of onset. The degree of microvascular injury was evaluated by Doppler guidewire. Adverse cardiac events were recorded during an average follow-up of 52+/-28 months. Using a receiver-operating characteristic analysis, a neutrophil count >or=7,260 cells/mm(3) was the best predictor of future cardiac events. By regression analysis, the neutrophil count significantly correlated with diastolic deceleration time (r=-0.40, p<0.0001), coronary flow reserve (r=-0.43, p<0.0001), and LV end-diastolic volume at 4 weeks (r=0.32, p<0.0001). Kaplan-Meier survival analysis showed a higher incidence of adverse cardiac events in patients with a high neutrophil count (p=0.002). By multivariate analysis, a neutrophil count >or=7,260 cells/mm(3) was an independent predictor of long-term adverse cardiac events (odds ratio 3.8, p=0.002). CONCLUSION: Neutrophilia on admission is associated with impaired microvascular perfusion, LV dilation, and long-term adverse cardiac events in patients treated with primary angioplasty for AMI.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2008) conducted a cohort in Acute Myocardial Infarction (n=228). Admission neutrophil count ≥7,260 cells/mm³ vs. Admission neutrophil count <7,260 cells/mm³ was evaluated on Long-term adverse cardiac events (cardiac death, recurrent AMI, and CHF requiring hospitalization) (OR 3.8, p=0.002). An admission neutrophil count ≥7,260 cells/mm³ was an independent predictor of long-term adverse cardiac events in patients treated with primary angioplasty for acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: